BCL2 and lung carcinoma: Montelukast significantly effects expression of COX-2 and Bcl-2 in A549 lung cancer cells, while no significant effect was detected in CL-15 lung cancer cells, despite montelukast inhibiting proliferation in both cell lines (21).